Collins, S.M., Surette, M. & Bercik, P. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol.10, 735–742 (2012). CASPubMed Google Scholar
Cryan, J.F. & Dinan, T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci.13, 701–712 (2012). CASPubMed Google Scholar
Sampson, T.R. & Mazmanian, S.K. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe17, 565–576 (2015). CASPubMedPubMed Central Google Scholar
Reaa, K., Dinan, T.G. & Cryan, J.F. The microbiome: a key regulator of stress and neuroinflammation. Neurobiol. Stress4, 23–33 (2016). Google Scholar
Deverman, B.E. & Patterson, P.H. Cytokines and CNS development. Neuron64, 61–78 (2009). CASPubMed Google Scholar
Stephan, A.H., Barres, B.A. & Stevens, B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci.35, 369–389 (2012). CASPubMed Google Scholar
Elmer, B.M. & McAllister, A.K. Major histocompatibility complex class I proteins in brain development and plasticity. Trends Neurosci.35, 660–670 (2012). CASPubMedPubMed Central Google Scholar
Weinstein, L.I., Revuelta, A. & Pando, R.H. Catecholamines and acetylcholine are key regulators of the interaction between microbes and the immune system. Ann. NY Acad. Sci.1351, 39–51 (2015). PubMed Google Scholar
Baganz, N.L. & Blakely, R.D. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem. Neurosci.4, 48–63 (2013). This reference extensively reviews the role of serotonin signaling and serotonin uptake in immune cell function, highlighting serotonergic pathways that are intrinsic to innate and adaptive immune cells. CASPubMed Google Scholar
Barragan, A., Weidner, J.M., Jin, Z., Korpi, E.R. & Birnir, B. GABAergic signalling in the immune system. Acta Physiol. (Oxf.)213, 819–827 (2015). CAS Google Scholar
Ben-Shaanan, T.L. et al. Activation of the reward system boosts innate and adaptive immunity. Nat. Med.22, 940–944 (2016). CASPubMed Google Scholar
Erickson, M.A., Dohi, K. & Banks, W.A. Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier. Neuroimmunomodulation19, 121–130 (2012). CASPubMedPubMed Central Google Scholar
Banks, W.A. The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav. Immun.44, 1–8 (2015). CASPubMed Google Scholar
Rook, G.A., Raison, C.L. & Lowry, C.A. Microbiota, immunoregulatory old friends and psychiatric disorders. Adv. Exp. Med. Biol.817, 319–356 (2014). CASPubMed Google Scholar
Nayak, D., Roth, T.L. & McGavern, D.B. Microglia development and function. Annu. Rev. Immunol.32, 367–402 (2014). CASPubMedPubMed Central Google Scholar
Matcovitch-Natan, O. et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science353, aad8670 (2016). PubMed Google Scholar
Nayak, D., Zinselmeyer, B.H., Corps, K.N. & McGavern, D.B. In vivo dynamics of innate immune sentinels in the CNS. Intravital1, 95–106 (2012). PubMed Google Scholar
Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science308, 1314–1318 (2005). CASPubMed Google Scholar
Bilbo, S.D. & Schwarz, J.M. The immune system and developmental programming of brain and behavior. Front. Neuroendocrinol.33, 267–286 (2012). CASPubMedPubMed Central Google Scholar
Hu, X. et al. Microglial and macrophage polarization—new prospects for brain repair. Nat. Rev. Neurol.11, 56–64 (2015). PubMed Google Scholar
Ransohoff, R.M. A polarizing question: do M1 and M2 microglia exist? Nat. Neurosci.19, 987–991 (2016). CASPubMed Google Scholar
Bogie, J.F.J., Stinissen, P. & Hendriks, J.J.A. Macrophage subsets and microglia in multiple sclerosis. Acta Neuropathol.128, 191–213 (2014). CASPubMed Google Scholar
Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci.18, 965–977 (2015). This study demonstrates the critical role of the microbiome in modulating microglial development and maintenance, particularly how short-chain fatty acids promote microglial maturity. CASPubMedPubMed Central Google Scholar
Borre, Y.E. et al. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol. Med.20, 509–518 (2014). PubMed Google Scholar
Smith, P.M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science341, 569–573 (2013). CASPubMed Google Scholar
Schafer, D.P. et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron74, 691–705 (2012). CASPubMedPubMed Central Google Scholar
Cho, I. et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature488, 621–626 (2012). CASPubMedPubMed Central Google Scholar
Khakh, B.S. & Sofroniew, M.V. Diversity of astrocyte functions and phenotypes in neural circuits. Nat. Neurosci.18, 942–952 (2015). CASPubMedPubMed Central Google Scholar
Jensen, C.J., Massie, A. & De Keyser, J. Immune players in the CNS: the astrocyte. J. Neuroimmune Pharmacol.8, 824–839 (2013). PubMed Google Scholar
Rossi, D. Astrocyte physiopathology: at the crossroads of intercellular networking, inflammation and cell death. Prog. Neurobiol.130, 86–120 (2015). CASPubMed Google Scholar
Barres, B.A. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron60, 430–440 (2008). CASPubMed Google Scholar
Dong, Y. & Benveniste, E.N. Immune function of astrocytes. Glia36, 180–190 (2001). CASPubMed Google Scholar
Rothhammer, V. et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med.22, 586–597 (2016). This study highlights how microbial metabolites of dietary tryptophan affect astrocytic inflammatory status, which modulates the severity of EAE. CASPubMedPubMed Central Google Scholar
Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity39, 372–385 (2013). CASPubMed Google Scholar
Wikoff, W.R. et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. USA106, 3698–3703 (2009). CASPubMedPubMed Central Google Scholar
Radjavi, A., Smirnov, I., Derecki, N. & Kipnis, J. Dynamics of the meningeal CD4+ T-cell repertoire are defined by the cervical lymph nodes and facilitate cognitive task performance in mice. Mol. Psychiatry19, 531–533 (2014). CASPubMed Google Scholar
Ribatti, D. The crucial role of mast cells in blood-brain barrier alterations. Exp. Cell Res.338, 119–125 (2015). CASPubMed Google Scholar
Forsythe, P. Microbes taming mast cells: implications for allergic inflammation and beyond. Eur. J. Pharmacol.778, 169–175 (2016). CASPubMed Google Scholar
Khosravi, A. et al. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe15, 374–381 (2014). CASPubMedPubMed Central Google Scholar
Lee, Y.K., Menezes, J.S., Umesaki, Y. & Mazmanian, S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA108 (Suppl. 1), 4615–4622 (2011). CASPubMed Google Scholar
Ochoa-Reparaz, J. et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol.183, 6041–6050 (2009). CASPubMed Google Scholar
Gaboriau-Routhiau, V. et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity31, 677–689 (2009). CASPubMed Google Scholar
Ivanov, I.I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell139, 485–498 (2009). CASPubMedPubMed Central Google Scholar
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H. & Kakuta, S. et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol.177, 566–573 (2006). CASPubMed Google Scholar
Round, J.L. et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science332, 974–977 (2011). CASPubMedPubMed Central Google Scholar
Round, J.L. & Mazmanian, S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA107, 12204–12209 (2010). CASPubMedPubMed Central Google Scholar
Ochoa-Reparaz, J. et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J. Immunol.185, 4101–4108 (2010). CASPubMed Google Scholar
Ochoa-Repáraz, J. et al. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol.3, 487–495 (2010). PubMed Google Scholar
Wang, Y. et al. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat. Commun.5, 4432 (2014)Refs. 51–53 describe roles forBacteroides fragilisderived PSA in neuroprotection from EAE through induction of regulatory T cell responses, highlighting the relationship between bacterially derived molecules, immune regulation and neuroinflammation. CASPubMed Google Scholar
Haghikia, A. et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity43, 817–829 (2015). CASPubMed Google Scholar
Kadowaki, A. et al. Gut environment-induced intraepithelial autoreactive CD4+ T cells suppress central nervous system autoimmunity via LAG-3. Nat. Commun.7, 11639 (2016). CASPubMedPubMed Central Google Scholar
Benakis, C. et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells. Nat. Med.22, 516–523 (2016). CASPubMedPubMed Central Google Scholar
Winek, K. et al. Depletion of cultivatable gut microbiota by broad-spectrum antibiotic pretreatment worsens outcome after murine stroke. Stroke47, 1354–1363 (2016). CASPubMedPubMed Central Google Scholar
Singh, V. et al. Microbiota dysbiosis controls the neuroinflammatory response after stroke. J. Neurosci.36, 7428–7440 (2016). Refs. 56–58 describe a role for the gut microbiota in the development of brain injury in the MCAO mouse model of stroke. MCAO results in intestinal dysbiosis, which regulates disease outcome through modulation of the adaptive immune system. CASPubMedPubMed Central Google Scholar
Houlden, A. et al. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav. Immun.57, 10–20 (2016). CASPubMedPubMed Central Google Scholar
Walsh, J.T. et al. MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4. J. Clin. Invest.125, 2547 (2015). PubMedPubMed Central Google Scholar
Gadani, S.P., Walsh, J.T., Smirnov, I., Zheng, J. & Kipnis, J. The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron85, 703–709 (2015). CASPubMed Google Scholar
Matsushita, T., Yanaba, K., Bouaziz, J.D., Fujimoto, M. & Tedder, T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest.118, 3420–3430 (2008). CASPubMedPubMed Central Google Scholar
Pöllinger, B. et al. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med.206, 1303–1316 (2009). PubMedPubMed Central Google Scholar
Yaddanapudi, K. et al. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol. Psychiatry15, 712–726 (2010). CASPubMed Google Scholar
Tennoune, N. et al. Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide α-MSH, at the origin of eating disorders. Transl. Psychiatry4, e458 (2014). CASPubMedPubMed Central Google Scholar
D'Mello, C. & Swain, M.G. Liver-brain interactions in inflammatory liver diseases: implications for fatigue and mood disorders. Brain Behav. Immun.35, 9–20 (2014). CASPubMed Google Scholar
Graff, L.A., Walker, J.R. & Bernstein, C.N. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm. Bowel Dis.15, 1105–1118 (2009). PubMed Google Scholar
D'Mello, C. et al. Probiotics improve inflammation-associated sickness behavior by altering communication between the peripheral immune system and the brain. J. Neurosci.35, 10821–10830 (2015). CASPubMedPubMed Central Google Scholar
Humann, J. et al. Bacterial peptidoglycan transverses the placenta to induce fetal neuroproliferation and aberrant postnatal behavior. Cell Host Microbe19, 388–399 (2016). CASPubMedPubMed Central Google Scholar
Ogbonnaya, E.S. et al. Adult hippocampal neurogenesis is regulated by the microbiome. Biol. Psychiatry78, e7–e9 (2015). PubMed Google Scholar
Möhle, L. et al. Ly6Chi monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis. Cell Rep.15, 1945–1956 (2016). This study demonstrates that the gut microbiota promote hippocampal neurogenesis in adult mice through recruitment of monocytes to the CNS. However, ref.74observed that the gut microbiota inhibit this process, suggesting complex interactions between intestinal microbes and neurogenesis. PubMed Google Scholar
Hsiao, E.Y. et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell155, 1451–1463 (2013). CASPubMedPubMed Central Google Scholar
Buffington, S.A. et al. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell165, 1762–1775 (2016). CASPubMedPubMed Central Google Scholar
Choi, G.B. et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science351, 933–939 (2016). This study demonstrates an important role for T cell–derived IL-17A in the development of behavioral abnormalities in the maternal immune activation mouse model of ASD, highlighting the relationship between immune dysregulation, neurophysiology and behavior. CASPubMedPubMed Central Google Scholar
Hsiao, E.Y., McBride, S.W., Chow, J., Mazmanian, S.K. & Patterson, P.H. Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc. Natl. Acad. Sci. USA109, 12776–12781 (2012). CASPubMedPubMed Central Google Scholar
Smith, S.E., Li, J., Garbett, K., Mirnics, K. & Patterson, P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci.27, 10695–10702 (2007). CASPubMedPubMed Central Google Scholar
Miller, A.H. & Raison, C.L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol.16, 22–34 (2016). CASPubMedPubMed Central Google Scholar
Diaz Heijtz, R. et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA108, 3047–3052 (2011). PubMed Google Scholar
Bercik, P. et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol. Motil.23, 1132–1139 (2011). CASPubMedPubMed Central Google Scholar
Desbonnet, L. et al. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience170, 1179–1188 (2010). CASPubMed Google Scholar
Arseneault-Bréard, J. et al. Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. Br. J. Nutr.107, 1793–1799 (2012). PubMed Google Scholar
Bravo, J.A. et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. USA108, 16050–16055 (2011). CASPubMedPubMed Central Google Scholar
De Palma, G. et al. Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat. Commun.6, 7735 (2015). CASPubMed Google Scholar
Zheng, P. et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol. Psychiatry21, 786–796 (2016). CASPubMed Google Scholar
Kelly, J.R. et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J. Psychiatr. Res.82, 109–118 (2016). PubMed Google Scholar
Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J. & Dinan, T.G. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J. Psychiatr. Res.43, 164–174 (2008). PubMed Google Scholar
Bellavance, M.A. & Rivest, S. The HPA – immune axis and the immunomodulatory actions of glucocorticoids in the brain. Front. Immunol.5, 136 (2014). This study discusses the immunomodulatory effects of glucocorticoids released by activation of the HPA axis, a neuroendocrine pathway that allows host adaptation to physical and psychological stress. PubMedPubMed Central Google Scholar
Hammond, C.J. et al. Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain. BMC Neurosci.11, 121 (2010). PubMedPubMed Central Google Scholar
Huang, W.S. et al. Association between Helicobacter pylori infection and dementia. J. Clin. Neurosci.21, 1355–1358 (2014). CASPubMed Google Scholar
Karim, S. et al. An association of virus infection with type 2 diabetes and Alzheimer's disease. CNS Neurol. Disord. Drug Targets13, 429–439 (2014). CASPubMed Google Scholar
Lurain, N.S. et al. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J. Infect. Dis.208, 564–572 (2013). CASPubMedPubMed Central Google Scholar
Pisa, D., Alonso, R., Rábano, A., Rodal, I. & Carrasco, L. Different brain regions are infected with fungi in Alzheimer's disease. Sci. Rep.5, 15015 (2015). CASPubMedPubMed Central Google Scholar
Prandota, J. Possible link between Toxoplasma gondii and the anosmia associated with neurodegenerative diseases. Am. J. Alzheimers Dis. Other Demen.29, 205–214 (2014). PubMed Google Scholar
Glass, C.K., Saijo, K., Winner, B., Marchetto, M.C. & Gage, F.H. Mechanisms underlying inflammation in neurodegeneration. Cell140, 918–934 (2010). CASPubMedPubMed Central Google Scholar
Kumar, D.K. et al. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci. Transl. Med.8, 340ra72 (2016). This study demonstrates that bacterial infection promotes amyloid-β peptide aggregation as an antimicrobial response, raising the question of whether neurodegeneration in Alzheimer's disease is causally associated with host responses to microbial infection. PubMed Google Scholar
Harach, T. et al. Reduction of Alzheimer's disease beta-amyloid pathology in the absence of gut microbiota. Preprint at https://arxiv.org/abs/1509.02273 (2015).
Minter, M.R. et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease. Sci. Rep.6, 30028 (2016). CASPubMedPubMed Central Google Scholar
Chapman, M.R. et al. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science295, 851–855 (2002). CASPubMedPubMed Central Google Scholar
Fröhlich, E.E. et al. Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication. Brain Behav. Immun.56, 140–155 (2016). PubMedPubMed Central Google Scholar
Wang, T. et al. Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats. Benef. Microbes6, 707–717 (2015). CASPubMed Google Scholar
Fasano, A., Visanji, N.P., Liu, L.W., Lang, A.E. & Pfeiffer, R.F. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol.14, 625–639 (2015). CASPubMed Google Scholar
Shannon, K.M. et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov. Disord.27, 709–715 (2012). PubMed Google Scholar
Scheperjans, F. et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord.30, 350–358 (2015). PubMed Google Scholar
Keshavarzian, A. et al. Colonic bacterial composition in Parkinson's disease. Mov. Disord.30, 1351–1360 (2015). CASPubMed Google Scholar
Devos, D. et al. Colonic inflammation in Parkinson's disease. Neurobiol. Dis.50, 42–48 (2013). CASPubMed Google Scholar
Forsyth, C.B. et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One6, e28032 (2011). CASPubMedPubMed Central Google Scholar
Chen, S.G. et al. Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged Fischer 344 rats and Caenorhabditis elegans. Sci. Rep.6, 34477 (2016). CASPubMedPubMed Central Google Scholar
Crack, P.J. & Bray, P.J. Toll-like receptors in the brain and their potential roles in neuropathology. Immunol. Cell Biol.85, 476–480 (2007). CASPubMed Google Scholar
Brenchley, J.M. & Douek, D.C. Microbial translocation across the GI tract. Annu. Rev. Immunol.30, 149–173 (2012). CASPubMedPubMed Central Google Scholar
Chakravarty, S. & Herkenham, M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci.25, 1788–1796 (2005). CASPubMedPubMed Central Google Scholar
Qin, L. et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia55, 453–462 (2007). PubMedPubMed Central Google Scholar
Arentsen, T. et al. The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior. Mol. Psychiatryhttp://dx.doi.org/10.1038/mp.2016.182 (2016).
Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & Bäckhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell165, 1332–1345 (2016). CASPubMed Google Scholar
Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature523, 337–341 (2015). This study identifies a network of lymphatic vessels in the meningeal spaces of the CNS, challenging the idea that the brain lacks an organized immune surveillance system. CASPubMedPubMed Central Google Scholar
Reigstad, C.S. et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J.29, 1395–1403 (2015). CASPubMed Google Scholar
Yano, J.M. et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell161, 264–276 (2015). CASPubMedPubMed Central Google Scholar
Lyte, M. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog.9, e1003726 (2013). PubMedPubMed Central Google Scholar
Gershon, M.D. & Tack, J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology132, 397–414 (2007). CASPubMed Google Scholar
Asano, Y. et al. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am. J. Physiol. Gastrointest. Liver Physiol.303, G1288–G1295 (2012). CASPubMed Google Scholar
Williams, B.B. et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe16, 495–503 (2014). CASPubMedPubMed Central Google Scholar
Borovikova, L.V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature405, 458–462 (2000). CASPubMed Google Scholar
van der Kleij, H., O'Mahony, C., Shanahan, F., O'Mahony, L. & Bienenstock, J. Protective effects of Lactobacillus rhamnosus and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. Am. J. Physiol. Regul. Integr. Comp. Physiol.295, R1131–R1137 (2008). CASPubMed Google Scholar
Ait-Belgnaoui, A. et al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology37, 1885–1895 (2012). CASPubMed Google Scholar
Demaude, J., Salvador-Cartier, C., Fioramonti, J., Ferrier, L. & Bueno, L. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut55, 655–661 (2006). CASPubMedPubMed Central Google Scholar
Moussaoui, N. et al. Changes in intestinal glucocorticoid sensitivity in early life shape the risk of epithelial barrier defect in maternal-deprived rats. PLoS One9, e88382 (2014). PubMedPubMed Central Google Scholar
Lennon, E.M. et al. Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10−/− mice. Inflamm. Bowel Dis.19, 712–719 (2013). CASPubMed Google Scholar
Gue, M., Junien, J.L. & Bueno, L. Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor. Gastroenterology100, 964–970 (1991). CASPubMed Google Scholar
Gué, M., Peeters, T., Depoortere, I., Vantrappen, G. & Buéno, L. Stress-induced changes in gastric emptying, postprandial motility, and plasma gut hormone levels in dogs. Gastroenterology97, 1101–1107 (1989). PubMed Google Scholar
Rubio, C.A. & Huang, C.B. Quantification of the sulphomucin-producing cell population of the colonic mucosa during protracted stress in rats. In Vivo6, 81–84 (1992). CASPubMed Google Scholar
Da Silva, S. et al. Stress disrupts intestinal mucus barrier in rats via mucin O-glycosylation shift: prevention by a probiotic treatment. Am. J. Physiol. Gastrointest. Liver Physiol.307, G420–G429 (2014). CASPubMed Google Scholar
Park, A.J. et al. Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol. Motil.25, 733–e575 (2013). CASPubMedPubMed Central Google Scholar
Hueston, C.M. & Deak, T. The inflamed axis: the interaction between stress, hormones, and the expression of inflammatory-related genes within key structures comprising the hypothalamic-pituitary-adrenal axis. Physiol. Behav.124, 77–91 (2014). CASPubMed Google Scholar
Tremlett, H. et al. Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur. J. Neurol.23, 1308–1321 (2016). PubMedPubMed Central Google Scholar
Chen, J. et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci. Rep.6, 28484 (2016). CASPubMedPubMed Central Google Scholar
Miyake, S. et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS One10, e0137429 (2015). PubMedPubMed Central Google Scholar
Cantarel, B.L. et al. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J. Investig. Med.63, 729–734 (2015). CASPubMedPubMed Central Google Scholar
Keshavarzian, A. et al. Colonic bacterial composition in Parkinson's disease. Mov. Disord.30, 1351–1360 (2015). CASPubMed Google Scholar
Bu, X.L. et al. A study on the association between infectious burden and Alzheimer's disease. Eur. J. Neurol.22, 1519–1525 (2015). PubMed Google Scholar
Gungor, B., Adiguzel, E., Gursel, I., Yilmaz, B. & Gursel, M. Intestinal microbiota in patients with spinal cord injury. PLoS One11, e0145878 (2016). PubMedPubMed Central Google Scholar
Fouts, D.E. et al. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J. Transl. Med.10, 174 (2012). CASPubMedPubMed Central Google Scholar
Aizawa, E. et al. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J. Affect. Disord.202, 254–257 (2016). PubMed Google Scholar
Jiang, H. et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav. Immun.48, 186–194 (2015). PubMed Google Scholar
Messaoudi, M. et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br. J. Nutr.105, 755–764 (2011). CASPubMed Google Scholar
Mohammadi, A.A. et al. The effects of probiotics on mental health and hypothalamic-pituitary-adrenal axis: a randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutr. Neurosci.19, 387–395 (2016). CASPubMed Google Scholar
Tomova, A. et al. Gastrointestinal microbiota in children with autism in Slovakia. Physiol. Behav.138, 179–187 (2015). CASPubMed Google Scholar
Wang, L. et al. Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol. Autism4, 42 (2013). CASPubMedPubMed Central Google Scholar
De Angelis, M. et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One8, e76993 (2013). CASPubMedPubMed Central Google Scholar
Kang, D.-W. et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One8, e68322 (2013). CASPubMedPubMed Central Google Scholar
Williams, B.L. et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One6, e24585 (2011). CASPubMedPubMed Central Google Scholar
Adams, J.B., Johansen, L.J., Powell, L.D., Quig, D. & Rubin, R.A. Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity. BMC Gastroenterol.11, 22 (2011). PubMedPubMed Central Google Scholar
Finegold, S.M. et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe16, 444–453 (2010). CASPubMed Google Scholar
Parracho, H.M.R.T., Bingham, M.O., Gibson, G.R. & McCartney, A.L. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol.54, 987–991 (2005). PubMed Google Scholar